← FDA Drug Approvals (Drugs@FDA)
VYNDAQEL
NDA · New Drug Application · Sponsor: FOLDRX PHARMS · Approved 2019-05-03
Drug application
- FDA Application #
NDA211996- Application type
- New Drug Application
- Brand name
- VYNDAQEL
- Generic name
- TAFAMIDIS MEGLUMINE
- Active ingredients
- TAFAMIDIS MEGLUMINE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- FOLDRX PHARMS
- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- First approval
- 2019-05-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown